Zinzino Preliminary Sales Report: October Shows 65% Increase

November 5, 2025
Press Release

Zinzino Preliminary Sales Report October 2025: Revenue increased a total of 65 %, as compared with the previous year.

The revenue in October for Zinzino‘s sales markets increased by 70 % and amounted to SEK 324.8 (191.6) million. Faun Pharma’s external sales decreased and amounted to SEK 2.7 (7.3) million.

Overall, the Group increased revenues by 65 % to SEK 327.5 (198.9) million compared with the previous year.

Accumulated revenue for January – October 2025 increased by 55 % to SEK 2,629.7 (1,693.2) million.

Revenues were distributed as follows:

Regions, MSEK	25-Oct	24-Oct	Change	YTD 2025	YTD 2024	Change
The Nordics	36.3	29.3	24%	270.3	243.3	11%
Central Europe	101.3	53.9	88%	758.9	448.3	69%
East Europe	34.4	34.5	0%	310.3	314.4	-1%
South & West Europe	57.8	37.0	56%	455.8	301.5	51%
The Baltics	13.0	10.1	29%	98.2	79.5	24%
North America	51.6	19.3	167%	433.6	153.3	183%
Asia-Pacific	28.1	5.8	384%	241.3	53.3	353%
Africa	2.3	1.7	35%	18.3	12.6	45%
Zinzino	324.8	191.6	70%	2586.7	1606.2	61%
Faun Pharma	2.7	7.3	-63%	43.0	87.0	-51%
Zinzino Group	327.5	198.9	65%	2629.7	1693.2	55%

Countries in regions:

– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

– Central Europe: Austria, Germany, Switzerland

– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

– The Baltics: Estonia, Latvia, Lithuania

– North America: Canada, USA, Mexico

– Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines

– Africa: South Africa

SOURCE: Zinzino

About Zinzino

Zinzino AB (publ) (ZZ-B.ST) is a global direct-sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market.

Zinzino’s scientifically proven nutritional supplements are available in more than 100 markets across the world. Zinzino has acquired all assets in the health and wellness companies Enhanzz Global, Truvy, Bodē Pro, Valentus, Zurvita and Xelliss. The company co-owns the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters are in Gothenburg, Sweden, with additional offices in Europe, Asia, and Australia. For more information, please visit www.zinzino.com

Get more information, facts and figures about Zinzino, click here for the Zinzino overview.

Disclaimer: At BFH, we strive to keep all content—articles, press releases, data—as accurate and current as possible at time of publishing. However, treat this content as a guide, not as definitive authority for business decisions. Publishing a press release does not imply Business For Home BV endorses a company or individual, nor guarantees its claims. No warranties or representations, expressed or implied, are made regarding the accuracy, completeness, or suitability of information provided on this website. All content is provided “as-is,” without liability for errors or usage. Always fact-check and conduct your own due diligence. BFH publishes press releases for the global Direct Selling / Network Marketing / Home Business community. Laws governing Direct Selling can vary greatly by country; BFH does not warrant that any company or content is in full compliance with various local or country-specific laws; it’s up to the reader to research, verify and comply with all applicable local regulations.

Ramesh Nair